Values First Advisors Inc. Sells 4,166 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
Values First Advisors Inc. trimmed its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 51.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,947 shares of the biopharmaceutical company’s stock after selling 4,166 shares during the quarter. Values First Advisors Inc.’s holdings […]
17 Oct 11:38 · The Markets Daily